Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
DETAILED ACTION
Priority
PNG
media_image1.png
56
342
media_image1.png
Greyscale
, is acknowledged.
Status of Claims
Claims 22-37 are currently pending in the application. Claims 38-41 have been cancelled.
Receipt is acknowledged of amendment / response filed on August 05, 2026 and that has been entered.
Information Disclosure Statement
Receipt is acknowledged of Information Disclosure Statement (IDS), filed on 08/13/2024, which has been entered in the file.
Response to Election/Restriction
In response to the restriction requirement Applicants have elected Group I, which includes claims 22-37, drawn to a compound of Formula II and the elected species as set forth and found to a compound and recited in claim 32, such as,
PNG
media_image2.png
134
182
media_image2.png
Greyscale
, without traverse, is acknowledged.
Claims 38-41 (currently cancelled) are withdrawn from further consideration pursuant to 37 C.F.R. 1.142 (b) as being drawn to a non-elected subject matter.
Applicants preserve their right to file a divisional on the non-elected subject matter.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 22-37 are rejected under 35 U.S.C. § 102(a)(1) as being anticipated by Alexander et al (2020). Applicant claims a compound of Formula II (Serotonin Receptor Agonists), pharmaceutical compositions and their method of uses thereof. Alexander et al also discloses an identical compound and composition, which anticipates the instantly claimed inventions [
PNG
media_image3.png
32
418
media_image3.png
Greyscale
PNG
media_image4.png
112
430
media_image4.png
Greyscale
, W1 is NR1, wherein R1 is hydrogen, W3 is NR1a, wherein R1a is alkyl and Z4 is CR4, wherein R4 is alkoxy group, STN International, CAPLUS database, Accession Number 2020 : 2543665, a copy is provided with this Office action].
Claims 22-37 are rejected under 35 U.S.C. § 102(a)(1) as being anticipated by Olson et al (2020). Applicant claims a compound of Formula II (Serotonin Receptor Agonists), pharmaceutical compositions and their method of uses thereof. Olson et al also discloses several identical compounds and compositions, which anticipate the instantly claimed inventions [
PNG
media_image5.png
338
446
media_image5.png
Greyscale
PNG
media_image3.png
32
418
media_image3.png
Greyscale
, W1 is NR1, wherein R1 is hydrogen, W3 is NR1a, wherein R1a is alkyl, Z4 is CR4, wherein R4 is alkoxy group, Z5 is CR5 , wherein R5 is alkyl or alkoxy group and Z6 is CR6, wherein R6 is alkoxy group, STN International, CAPLUS database, Accession Number 2020 : 1716155, a copy is provided with this Office action].
Claims 22-37 are rejected under 35 U.S.C. § 102(a)(1) as being anticipated by Matsumura et al (2017). Applicant claims a compound of Formula II (Serotonin Receptor Agonists), pharmaceutical compositions and their method of uses thereof. Matsumura et al also discloses several identical compound and compositions, which anticipate the instantly claimed inventions [
PNG
media_image6.png
282
418
media_image6.png
Greyscale
PNG
media_image3.png
32
418
media_image3.png
Greyscale
, W1 is O, W3 is NR1a, wherein R1a is hydrogen or alkyl group and Z4 is CR4, wherein R4 is alkoxy group, STN International, CAPLUS database, Accession Number 2017 : 932518, a copy is provided with this Office action].
Telephone Inquiry
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Golam Shameem, Ph.D. whose telephone number is (571) 272-0706. The examiner can normally be reached on Monday-Thursday from 7:30 AM - 6:00 PM. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Clinton Brooks, Ph.D. can be reached at (571) 270-7682.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://portal.uspto.gov/external/portal. Should you have questions about access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free).
Any inquiry of a general nature or relating to the status of this application should be directed to the Group receptionist, whose telephone number is (571) 272-1600.
/GOLAM M SHAMEEM/Primary Examiner, Art Unit 1621